Research Articles

November 01, 2021

New Estimate Shows Communities in New Jersey Have an Autism Prevalence at 5 Percent or Higher

SafeMinds had the pleasure of conversing with Walter M. Zahorodny, Ph.D., co-author of the new report, “Prevalence of autism spectrum disorder in a large, diverse metropolitan area: Variation by sociodemographic factors.” He is an Associate Professor of Pediatrics at Rutgers New Jersey Medical School.

October 25, 2021

Supplemental Security Income Increases in 2022

Benefits Will Rise by 5.9%, Representing the Biggest Boost in Decades  Individuals with disabilities who receive Supplemental Security Income (SSI) and other Social Security benefits will see the largest increase in their monthly payments since 1982. Earlier this month, the Social Security Administration announced that benefits will grow 5.9% in 2022. For the past ten […]

October 25, 2021

IACC Requests Public Comments for Their 2021-22 Strategic Plan

Input Accepted Between October 1 – November 30, 2021 After experiencing a two year-hiatus and appointing a new panel, the Interagency Autism Coordinating Committee (IACC) is now looking for public feedback in order to update its strategic plan. The new input will be used to drive the federal government’s autism agenda and will also set […]

October 18, 2021

Telehealth Could Be the Answer for Early Evaluation’s Long Waitlists

Caregivers concerned about their infant’s development are often told to “wait and see” by providers. This delay, in many instances, squanders valuable evaluation, diagnostic, and treatment time.

October 18, 2021

How Effective is Preemptive ASD Intervention for At-Risk Infants?

A fascinating new investigation published in JAMA Pediatrics has determined that preemptive intervention for infants showing early behavioral signs of autism led to a significant reduction in the severity of ASD behaviors in early childhood. 

October 18, 2021

Oxytocin Trial Reveals Disappointing Results

An original article published in the New England Journal of Medicine has delivered disappointing news for parents and researchers counting on positive results in an oxytocin clinical trial for children with autism.

Show Buttons
Hide Buttons